Qube Research & Technologies (QRT)
CHNG

Qube Research & Technologies (QRT)’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CHNG Stock Details CHNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-924,488
Closed -$21.3M – 3248
2022
Q2 		$21.3M Buy
924,488
+444,288
+93% +$10.4M 0.16% 163
2022
Q1 		$10.5M Buy
480,200
+34,554
+8% +$717K 0.09% 293
2021
Q4 		$9.53M Buy
445,646
+376,638
+546% +$7.9M 0.07% 358
2021
Q3 		$1.45M Sell
69,008
-82,392
-54% -$1.8M 0.02% 778
2021
Q2 		$3.49M Sell
151,400
-79,973
-35% -$1.84M 0.04% 521
2021
Q1 		$5.11M Buy
+231,373
New +$5.36M 0.08% 322
2020
Q4 		– Sell
-31,534
Closed -$458K – 2316
2020
Q3 		$458K Buy
+31,534
New +$401K 0.01% 1076
2020
Q2 		– Sell
-108,982
Closed -$1.09M – 2084
2020
Q1 		$1.09M Buy
+108,982
New +$1.52M 0.04% 361
2019
Q4 		– Sell
-70,126
Closed -$847K – 1604
2019
Q3 		$847K Hold
70,126
– – 0.56% 45
2019
Q2 		$1.02M Buy
+70,126
New +$1.04M 0.24% 103

Other funds holding CHNG

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CHNG Position: Q3 2022 in Review

Qube Research & Technologies (QRT) sold out of Change Healthcare Inc. Common Stock (CHNG) in Q3 2022, closing a stake of 924,488 shares — an estimated $21.3M sold.

Qube Research & Technologies (QRT) first reported a position in CHNG in Q2 2019 and held it in 10 quarters. The position peaked at $21.3M in Q2 2022. 263 funds tracked by Wall St. Rank hold CHNG as of Q3 2022.

  • Qube Research & Technologies (QRT) reported no remaining Change Healthcare Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 924,488 Change Healthcare Inc. Common Stock shares in Q3 2022, an estimated $21.3M.
  • Qube Research & Technologies (QRT) first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Change Healthcare Inc. Common Stock position peaked at $21.3M in Q2 2022.
  • 263 funds tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q3 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.